The Third Wave

What do endo-nasal balloons, suppositories, methylene blue, and cerebrospinal fluid have to do with psychedelics? In this fascinating and eye-opening discussion, Paul and Dr. John talk about some surprising tools of the chiropractic neurologist trade, how they can be used in conjunction with ceremony, and what they mean for our stressed-out world.

From an early age, Daniel Cleland knew that the cookie-cutter life was not for him. His desire for travel, entrepreneurship, and non-traditional experiences brought him to the heart of the jungle, where he overcame his fear of ayahuasca and found deep healing. Since then, he’s been dedicated to sharing the restorative powers of this medicine with others, and has co-founded Soltara Healing Center to bring this mission to life. In this episode, Daniel and Paul discuss the challenges and rewards of starting an ayahuasca retreat, the importance of tradition, and how he envisions Soltara moving forward.

What is social sculpture, and how can it uplift humanity? How does an entheogen differ from a psychedelic? What is the “universal mind lattice”? Can psychedelics save your life? In this expansive discussion, Paul Austin and legendary visionary artists Allyson and Alex Grey cover all this and much more, including the symbolic communication of the Divine.

As one of the earliest researchers and advocates for ketamine’s use in healing pain, depression, and addiction, Jeffrey Becker, M.D., is on the forefront of harnessing ketamine’s massive untapped potential. In addition to his personal functional psychiatry practice, Jeff is the co-founder and CSO of Bexson Biomedical, which has created a subcutaneous ketamine infusion pump for safe, at-home pain management. In this episode, Jeff and Paul enjoy a wide-ranging discussion about responsible use of psychedelics, the connections between mysticism and science, and the fragile future of these powerful substances.

In the three years since Paul and Sean last spoke, there has been huge growth in the psychedelic space, from legal retreats and clinics to corporate interest to personal education and use. In this episode, recorded for Sean’s podcast and shared here as well, Paul and Sean discuss the revolutionary changes psychedelics are bringing to mental and physical healthcare, as well as exciting upheavals in industrial capitalism, religion, and our concept of a sovereign state.

We’re in the early stages of a many-layered worldwide shift: The paternalistic medical model is slowly falling away as we recognize that we’re our own best healers. With church affiliation dwindling, more and more of us are turning to different forms of community and spirituality. And as psychedelics continue to grow in mainstream awareness, support of their use in healing and personal growth is gaining unstoppable momentum. In this episode, Michael and Paul discuss some of the exciting possibilities of our psychedelic medical future, and how these substances have the power to heal not just ourselves, but our entire communities.

What do the ancient mysteries of psychedelics have to do with the modern technology of cryptocurrency? There are several surprising similarities, including global interconnectedness, the move toward personal freedom and sovereignty, and long-term sustainability. In this episode, Paul Austin talks with Brandon Quittem, entrepreneur and enthusiastic Bitcoiner, about the curious overlaps between psychedelics, the mycelium network, Bitcoin, the healthcare system, original American values, and the empowerment of the entire world.

Keith Kurlander has practiced integrative psychotherapy and coaching with individuals, couples and groups for over 15 years. After years of treating highly complex patients, as well as a personal journey of overcoming trauma and mental illness, he turned toward integrative psychiatric practices as a key component to achieving mental health and understanding the healing process. In this episode, he and Paul discuss the core areas to focus on when getting well, the role of psychedelics in healing mental illness and trauma, and the importance of a well-trained therapist and guide.

After a successful career in entrepreneurship and cryptocurrency, Ryan Zurrer turned his attention to the burgeoning psychedelic space. As he continued to learn more via research, attending conferences, and speaking with others, he became concerned about what he considers the “dystopian future” of psychedelic therapies - sterile doctors’ offices, $8000 treatments, synthetic drugs, no community or connection. Determined to help others harness the powerful benefits of plant medicines in traditional settings, he started Vine Ventures, a VC fund focusing on a future in which everyone who wants to access a psychedelic experience can do so safely, legally, and affordably. In this episode, Ryan and Paul discuss the importance of accessibility, Ryan’s criteria for investment, and the differences between a centralized and decentralized approach to therapy and legalization.

When Lynn Marie Morski, M.D., was first introduced to psychedelics at age 35, she had the kind of transformative experience that she knew would greatly help her patients at the VA. But with no legal way to recommend plant medicines, she decided to turn her attention to educating doctors about the benefits of psychedelics. Unsure of where her new venture would take her, Lynn Marie quit her job, started the Plant Medicine podcast, and created the Psychedelic Medicine Association. In this episode, Lynn Marie and Paul discuss bridging the gap between medical practitioners and the advances taking place in the psychedelic research world.

Psychoanalyst, executive coach, author, and Harvard-trained philosopher Peter Carnochan, Ph.D., has spent the last 30 years helping clients unknot problematic feelings, solve challenges, and develop more resilient and expansive modes of living. In this episode, Peter talks with Paul about the many ways philosophy and psychedelic experiences complement each other, the interconnectedness of everything in the universe, the freedom found within boundaries, and the power we have to change our own lives.

When it comes to contemplative practices, concepts of eternity, and mystical experiences, there are many similarities between ancient traditions and contemporary religions. Could psychedelics be one of those connections? In this episode, Paul Austin talks with Brian Muraresku, author of The Immortality Key: The Secret History of the Religion with No Name, about tens of thousands of years of mysticism, the evidence for ancient use of psychedelics in religious ceremony, and the democratization of plant medicine.

One of the leading advocates in the kratom industry, Mac Haddow spent years working in US government relations, including acting as Chief of Staff at the US Department of Health and Human Services. Today, he is working tirelessly to protect the rights of kratom users and vendors, traveling throughout the US to promote nationwide adoption of the Kratom Consumer Protection Act. In this episode, Mac and Paul discuss the responsible use of kratom—its benefits, risks, and concerns—and also touch on the topic of corruption within the FDA regulatory and approval process.

There’s a growing momentum to legalize therapeutic psychedelics in the United States, with clinics nationwide already offering ketamine therapy, as well as the recent decriminalization of psilocybin in Oregon. What do today’s treatment protocols look like, and what will the future bring? In this episode, Yaron Conforti, CEO and Director of Novamind, talks with Paul Austin, founder of Third Wave, about creating individualized treatment plans, the thousands of clinics we can expect in the next ten years, and democratizing access to psychedelic medicine.

After building and selling a successful software startup, Tim Sae Koo had a psychedelic experience and vision that revealed his true life’s purpose. Today, he devotes himself to 1heart, a home for change makers, creative innovators, and soul seekers who feel called to co-create a collective future as one tribe. In this episode, Tim and Paul reflect on their friendship, and discuss elevating consciousness, building community, and staying out of the matrix.

James Fadiman Ph.D. almost needs no introduction. An early pioneer of psychedelic research, a lifelong proponent of microdosing, and a prolific writer and educator, Jim played a pivotal role in reigniting the conversation around psychedelics in the US and beyond with the publication of his 2011 book, The Psychedelic Explorer’s Guide. In this wide-ranging podcast, Jim chats candidly with Paul Austin about everything from the early years of psychedelic research and the immeasurable benefits of microdosing, to the business of psychedelics, the power of citizen science, and the foundation of our personal identities.

Dr. Katherine Coder was on her way to a career on Wall Street when a psychedelic experience changed the course of her life. Now a counselor and coach, her mission is to help her clients reclaim their birthright and unfold their essential nature into the world. In this episode, Kat and Paul discuss the power of community, connecting to spirit, and pharmaceutical vs. shamanic approaches to healing through plant medicine.

Amanda Eilian has been actively investing in early stage consumer companies for the last decade, drawing on her experience as an institutional investor and entrepreneur. Her focus today is on companies that make the daily lives of consumers healthier, happier, and more meaningful. In this episode, Amanda and Paul discuss narrowing the wellness gap and investing in psychedelics for long-term solutions to mental illness.

A psychotherapist since 1989, Charley Wininger is also a licensed psychoanalyst and a mental health counselor who specializes in relationships and communication skills. His recent book, Listening To Ecstasy, tracks his personal experience with MDMA as a way to enhance his life and strengthen his marriage. In this podcast, he and Paul chat about the power of MDMA to solidify relationships, rediscover joy, and reconnect to ourselves and each other.

Dr. Craig Heacock, psychiatrist and ketamine treatment provider, offers a counterpoint to a previous guest’s view on mental illness and psychiatric medications. While his goal is always to have patients on as few medications as possible, Craig stresses the importance of correctly understanding the nuances of mental health and mental health treatments instead of painting with a broad brush. He and Paul also discuss the current state and near-future of psychedelic treatments for mental health, as well as the reception of psychedelics among the psychiatric community.